|
|
Article: The position not the presence of the halogen in corticosteroids influences potency and side effects.
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- February 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Abstract
Many topical corticosteroids currently on the market contain a halogen substitution at the [C.sub.6], [C.sub.9], or the side-chain [C.sub.21] position of the corticosteroid skeleton. These modifications have enhanced the efficacy of corticosteroids as compared to hydrocortisone as topical anti-inflammatory agents, but have often increased side effects such as skin atrophy, adrenal suppression, and telangiectasia. These side effects have been attributed to the presence of halogens in the corticosteroid molecule and have raised concerns regarding the safety of all halogenated corticosteroids. In this review, we assert that it is the position and nature of ...
Related newspaper, magazine, and journal articles:
|
|
Article: Reducing the Side Effects of Managed Care
Dynamic Chiropractic;
January 29, 2007 ;
700+ words
... ... to reduce the negative side effects of managed care's management ... What keeps them as sub-efficient tools is ... rather than overcoming the side effects of required documentation ... the end, we get those side effects, such as stress, lost ...
|
|